NOV 15, 2018
Science
Science Advisory Board review meeting took place on November 2
We have shared our latest R&D progress with our Science Advisory (SAB) review panel that…
AUG 31, 2018
Business
Machavert closes A round financing of $4.5m
Machavert has closed their A Round of financing of ~$4.5m by raising $2.2 million in the second…
JUL 31, 2018
Business
Machavert’s Annual General Meeting
Machavert’s Shareholders Annual General Meeting took place on June 27th in Prague, Czech…
JUL 26, 2018
People
Leading immuno-oncologist Norman Michael Greenberg joins Science Advisory Board of Machavert
We are very happy to welcome Dr. Norman Michael Greenberg to our Science Advisory Board (SAB).
MAR 6, 2018
Science
We welcomed Prof. David Brautigan to his first meeting at our Science Advisory Board
David travelled from Charlottesville, Virginia to visit Machavert headquarters at Anschutz…
FEB 8, 2018
Business
Shareholders General Meeting
Machavert’s Shareholders General Meeting took place on February 6 in Prague, Czech Republic.
FEB 1, 2018
People
Dr. Neal Goodwin joins Machavert as Chief Science Officer
Machavert is excited to introduce Dr. Neal Goodwin, Ph.D. as the Chief Science Officer who will…
JAN 17, 2018
People
Machavert welcomes Dennis R. Voelker as a member of Science Advisory Board
Dennis R. Voelker is Professor in the Department of Medicine and Director of Research, Pulmonary…
DEC 11, 2017
People
Meet Dan Theodorescu of the recently established Science Advisory Board
Dan Theodorescu is the Director of the NCI designated Comprehensive Cancer Center at the…